Translating clinical trials from human to veterinary oncology and back

Irene Fürdös, Judit Fazekas, Josef Singer, Erika Jensen-Jarolim*

*Corresponding author for this work

Research output: Journal article (peer-reviewed)Review article

24 Citations (Scopus)

Abstract

In human medicine clinical trials are legally required for drug development and approval. In contrast, clinical trials in small animal cancer patients are less common and legally perceived as animal experiments. Comparative oncology has been recognized as a method to speed up the development of medications by introducing animal patients with naturally developing tumours. In such cases, using animal patients would generate more robust data, as their spontaneous disease resembles the "real life" situation and thus could be more likely to predict the situation in human disease. This would not only provide veterinary oncology access to the latest developments in medicine before they are available for clinical use in animals, but could also lead to generation of clinical data in animal patients that could be translated to humans. Nevertheless, there are several limitations to practical conduct of clinical trials in veterinary medicine. In this review, the possible application of similar standards of Good Clinical Practice as in human clinical drug development will be discussed in detail, with special consideration of legal and ethical aspects in Europe and the US.

Original languageEnglish
Article number265
JournalJournal of Translational Medicine
Volume13
Issue number1
DOIs
Publication statusPublished - 15 Aug 2015
Externally publishedYes

Keywords

  • Canine
  • Clinical trials
  • Dog
  • Human medicine
  • Oncology
  • Translational
  • Veterinary medicine

ASJC Scopus subject areas

  • General Biochemistry,Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Translating clinical trials from human to veterinary oncology and back'. Together they form a unique fingerprint.

Cite this